Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BIOVOX is a Germany-based private company developing and supplying sustainable medical-grade bioplastics for healthcare applications. Its materials are designed for medical technology, pharmaceutical, laboratory, and sterile packaging uses, with a focus on renewable feedstocks, recyclability, regulatory compliance, and biocompatibility. The company markets its MedEco product family for applications such as injection molding, extrusion, films, tubes, drug-delivery devices, and pharmaceutical packaging. BIOVOX operates under an ISO 13485-certified quality management system and highlights ISO 10993 biological safety testing for its materials. Rather than a therapeutic drug developer, BIOVOX is a commercial-stage healthcare materials platform company serving medtech and pharma manufacturers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BIOVOX.